{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:47:38Z","timestamp":1789501658699,"version":"build-2803163510"},"reference-count":22,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,20]]},"DOI":"10.26633\/rpsp.2025.23","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:50:51Z","timestamp":1739962251000},"page":"1","source":"Crossref","is-referenced-by-count":8,"title":["Oropouche virus \u2013 another antecedent event for Guillain\u2013Barr\u00e9 syndrome?"],"prefix":"10.26633","volume":"49","author":[{"given":"Alina","family":"Gonz\u00e1lez-Quevedo","sequence":"first","affiliation":[{"name":"https:\/\/orcid.org\/0000-0003-1952-4704"},{"name":"Neurobiology Department, Institute of Neurology and Neurosurgery, Havana, Cuba."},{"name":"gonzalezquevedoalina@gmail.com"},{"name":"aglez@infomed.sld.cu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zurina","family":"Lestayo O\u2019Farrill","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0001-8945-0339"},{"name":"Neurology Department, Institute of Neurology and Neurosurgery, Havana, Cuba."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo","family":"Mustelier Becquer","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0003-1946-3454"},{"name":"Neurology Department, Institute of Neurology and Neurosurgery, Havana, Cuba."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11167","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021;397(10280):1214\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(21)00517-1","DOI":"10.1016\/S0140-6736(21)00517-1"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Habib AA, Waheed W. Guillain-Barr\u00e9 syndrome. Continuum (Minneap Minn). 2023;29(5):1327\u201356. https:\/\/doi.org\/10.1212\/CON.0000000000001289","DOI":"10.1212\/CON.0000000000001289"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Arriaga-Nieto L, Hern\u00e1ndez-Bautista PF, Vallejos-Par\u00e1s A, Grajales-Mu\u00f1iz C, Rojas-Mendoza T, Cabrera-Gayt\u00e1n DA, et al. Predict the incidence of Guillain Barre syndrome and arbovirus infection in Mexico, 2014\u20132019. PLOS Glob Public Health. 2022;2(3):e0000137. https:\/\/doi.org\/10.1371\/journal.pgph.0000137","DOI":"10.1371\/journal.pgph.0000137"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ripellino P, Schreiner B, Latorre D. Expanding our understanding of Guillain-Barr\u00e9 syndrome: recent advances and clinical implications. Eur J Immunol. 2024;54(11):e2250336. https:\/\/doi.org\/10.1002\/eji.202250336","DOI":"10.1002\/eji.202250336"},{"key":"ref5","unstructured":"Estrada J, Goyenechea A, Herrera C. [Acute polyradiculoneuritis outbreak type Landry-Guillain-Barr\u00e9-Strohl during a dengue epidemic]. Rev Cub Hig Epid. 1981;19:256\u201365. [Spanish]"},{"key":"ref6","unstructured":"Gonz\u00e1lez-Quevedo Monteagudo A, Santiesteban Freixas R, Lestayo O\u2019Farrill Z, Machado Curbelo C. The association of Guillain-Barr\u00e9 syndrome with dengue fever was first described in Cuba. An Acad Cienc Cuba. 2024;14(1):e1464."},{"key":"ref7","unstructured":"World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations (IHR 2005) regarding microcephaly, other neurological disorders and Zika virus 2016. Geneva: WHO; 2016 [cited 2024 Sep 23]. Available from: http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/zika-fifth-ec\/en\/"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Matos LM, Borges AT, Palmeira AB, Lima VM, Maciel EP, Fern\u00e1ndez RNM, et al. Frequency of exposure to arboviruses and characterization of Guillain Barr\u00e9 syndrome in a clinical cohort of patients treated at a tertiary referral center in Bras\u00edlia, Federal District. Rev Soc Bras Med Trop. 2022;55:e03062021. https:\/\/doi.org\/10.1590\/0037-8682-0306-2021","DOI":"10.1590\/0037-8682-0306-2021"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Sakkas H, Bozidis P, Franks A, Papadopoulou C. Oropouche fever: a review. Viruses. 2018;10(4):175. https:\/\/doi.org\/10.3390\/v10040175","DOI":"10.3390\/v10040175"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Travassos da Rosa JF, de Souza WM, Pinheiro FP, Figueiredo ML, Cardoso JF, Acrani GO, et al. Oropouche virus: clinical, epidemiological, and molecular aspects of a neglected orthobunyavirus. Am J Trop Med Hyg. 2017;96(5):1019\u201330. https:\/\/doi.org\/10.4269\/ajtmh.16-0672","DOI":"10.4269\/ajtmh.16-0672"},{"key":"ref11","unstructured":"Pan American Health Organization\/World Health Organization. Epidemiological alert: Oropouche in the region of the Americas, 9 May 2024. Washington, DC: PAHO\/WHO; 2024 [cited 2024 Sep 23]. Available from: https:\/\/www.paho.org\/en\/documents\/epidemiological-alert-oropouche-region-americas-9-may-2024"},{"key":"ref12","unstructured":"Pan American Health Organization\/World Health Organization. Epidemiological alert: Oropouche in the region of the Americas, 15 Oct 2024. Washington, DC: PAHO\/WHO; 2024 [cited: 2024 Oct 17]. Available from: https:\/\/www.paho.org\/en\/file\/152348\/download?token=-0Gi74AQ"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Benitez AJ, Alvarez M, Perez L, Gravier R, Serrano S, Hernandez DM, et al. Oropouche fever, Cuba, May 2024. Emerg Infect Dis. 2024;30(10):2155\u20139. https:\/\/doi.org\/10.3201\/eid3010.2409002024","DOI":"10.3201\/eid3010.240900"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Chiang JO, Azevedo RS, Justino MCA, Matos HJ, Cabe\u00e7a HLS, Silva SP, et al. Neurological disease caused by Oropouche virus in northern Brazil: should it be included in the scope of clinical neurological diseases? J Neurovirol. 2021;27(4):626\u201330. https:\/\/doi.org\/10.1007\/s13365-021-00987-9","DOI":"10.1007\/s13365-021-00987-9"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"de Armas Fern\u00e1ndez J, Pe\u00f1a Garc\u00eda C, Acosta Herrera B, Betancourt Plaza I, Guti\u00e9rrez de la Cruz Y, Resik Aguirre S, et al. Report of an unusual association of Oropouche fever with Guillain-Barr\u00e9 syndrome in Cuba, 2024. Eur J Clin Microbiol Infect Dis. 2024;43(11):2233\u20137. https:\/\/doi.org\/10.1007\/s10096-024-04941-5","DOI":"10.1007\/s10096-024-04941-5"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Martins-Filho PR, Carvalho TA, Dos Santos CA. Spatiotemporal epidemiology of Oropouche fever, Brazil, 2015\u20132024. Emerg Infect Dis. 2024;30(10):2196\u20138. https:\/\/doi.org\/10.3201\/eid3010.241088","DOI":"10.3201\/eid3010.241088"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Naveca FG, Almeida TAP, Souza VS, Nascimento V, Silva D, Nascimento F, et al. Human outbreaks of a novel reassortant Oropouche virus in the Brazilian Amazon region. Nat Med. 2024;30(12):3509\u201321. https:\/\/doi.org\/10.1038\/s41591-024-03300-3","DOI":"10.1038\/s41591-024-03300-3"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Bandeira AC, Pereira FM, Leal A, Santos SPO, Barbosa AC, Souza MSPL, et al Fatal Oropouche virus infections in nonendemic region, Brazil, 2024. Emerg Infect Dis. 2024;30(11). https:\/\/doi.org\/10.3201\/eid3011.241132","DOI":"10.3201\/eid3011.241132"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Bastos M de S, Figueiredo LT, Naveca FG, Monte RL, Lessa N, Pinto de Figueiredo RM, et al. Identification of Oropouche orthobunyavirus in the cerebrospinal fluid of three patients in the Amazonas, Brazil. Am J Trop Med Hyg. 2012;86(4):732\u20135. https:\/\/doi.org\/10.4269\/ajtmh.2012.11-0485","DOI":"10.4269\/ajtmh.2012.11-0485"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Lynch RM, Mantus G, Encinales L, Pacheco N, Li G, Porras A, et al. Augmented Zika and dengue neutralizing antibodies are associated with Guillain-Barr\u00e9 syndrome. J Infect Dis. 2019;219(1):26\u201330. https:\/\/doi.org\/10.1093\/infdis\/jiy466","DOI":"10.1093\/infdis\/jiy466"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Vieira MADCES, Cruz ACR, Barros ANM, Costa DL, Silva EVPD, Batista FMA, et al. Guillain-Barr\u00e9 syndrome and dengue-like disease in 2015: temporal relationship in Piau\u00ed state and implications on Zika virus surveillance. Rev Inst Med Trop Sao Paulo. 2017;59:e22. https:\/\/doi.org\/10.1590\/S1678-9946201759022","DOI":"10.1590\/s1678-9946201759022"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Geddes VEV, Brustolini OJB, Cavalcante LTdF, Moreira FRR, de Castro FL, Guimar\u00e3es APdC, et al. Common dysregulation of innate immunity pathways in human primary astrocytes infected with Chikungunya, Mayaro, Oropouche, and Zika viruses. Front Cell Infect Microbiol. 2021;11:641261. https:\/\/doi.org\/10.3389\/fcimb.2021.641261","DOI":"10.3389\/fcimb.2021.641261"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/64703\/v49e232025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:50:58Z","timestamp":1739962258000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/64703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":22,"alternative-id":["RPSP.2025.23"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2025.23","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}